EnGene Therapeutics is laying off roughly 40 employees as it focuses its remaining resources on getting its bladder cancer ...
The deal follows other transactions that have, in part, led to a reduction in St. Louis' count of locally based public firms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results